Top Story

Top 5 lessons learned at SGO's Women's Cancer Annual Meeting

April 27, 2015

Surgical and medical approaches to ovarian cancer, sentinel node mapping for endometrial cancer, the use of tissue morcellation for uterine tissue extraction, and the 9-Valent HPV vaccine were among the key topics presented at the 2015 Society of Gynecologic Oncology’s Women’s Cancer Annual Meeting.
“We heard presentations from various speakers on topics that have generated great excitement,” Nadeem R. Abu-Rustum, MD, meeting program committee chair, told HemOnc Today. “We heard some encouraging findings, and some interesting debates.
The following are the top five lessons learned from the 2015 Society of Gynecologic Oncology’s (SGO) Women’s Cancer Annual Meeting.

1. The use of standard chemotherapy plus bevacizumab confers a survival benefit in patients with ovarian cancer.

Health Care Legislative and Regulatory Update

Act III for meaningful use — The EHR incentive program Stage 3 proposed rule

April 27, 2015
CMS issued its Stage 3 Meaningful Use Proposed Rule on March 30 (Proposed Rule). Stage 3 is expected to be the final stage of the Electronic Health Record (EHR)…
VIDEO: Ipilimumab plus nivolumab conferred high response rates in melanoma Meeting News CoverageVideo

VIDEO: Ipilimumab plus nivolumab conferred high response rates in melanoma

April 27, 2015
F. Stephen Hodi, Jr., MD, director of the melanoma center at Dana-Farber Cancer Institute and associate professor of medicine at Harvard Medical School,
Highlights from the 2015 HemOnc Today Melanoma and Cutaneous Malignancies meeting Meeting News CoverageVideo

Highlights from the 2015 HemOnc Today Melanoma and Cutaneous Malignancies meeting

April 26, 2015
NEW YORK — Sanjiv S. Agarwala, MD, professor of medicine at Temple University School of Medicine, chief of hematology and oncology at St. Luke’s Cancer…
Meeting News Coverage

Next generation sequencing increases actionable mutation detection in malignant melanoma

April 26, 2015
NEW YORK — The use of next-generation sequencing in multi-gene targeted panel testing identified a considerable number of actionable mutations among patients with…
More News Headlines »
CME CNE
Stem Cell Transplant for AAMDS

Treatment Decision-Making through the Spectrum of MDS:
Case 3 Stem Cell Transplant for MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain to…
More »
Meeting News Coverage Video
Highlights from the 2015 HemOnc Today Melanoma and Cutaneous Malignancies meeting

Highlights from the 2015 HemOnc Today Melanoma and Cutaneous Malignancies meeting

April 26, 2015
NEW YORK — Sanjiv S. Agarwala, MD, professor of medicine at Temple University School of Medicine, chief of…
More »
CME
Activity cover

Targeted Therapy and Immunotherapy in the Management of Metastatic Melanoma: 2014 Updates

This activity is supported by an educational grant from Merck & Co., Inc.

Melanoma remains a challenging condition for clinicians. An array of targeted therapies and immunotherapy are in…
More »
morganatic-roan